5,924 Call Contracts Traded on Divis Laboratories Ltd as Stock Edges Closer to 52-Week High

2 hours ago
share
Share Via
On 18 Aug 2026, 5,924 call contracts on Divis Laboratories Ltd changed hands at the Rs 8,600 strike price, with the stock closing at Rs 8,615. This near-the-money activity coincided with a 1.36% gain in the cash market, signalling a strong alignment between derivatives positioning and underlying price momentum.
5,924 Call Contracts Traded on Divis Laboratories Ltd as Stock Edges Closer to 52-Week High

Options Event and Cash Market Price Action

The call option activity on Divis Laboratories Ltd was concentrated at the Rs 8,600 strike, just Rs 15 below the closing price of Rs 8,615 on 17 Aug 2026. With 5,924 contracts traded against an open interest of 2,486, the contracts-to-open interest ratio stands at approximately 2.38:1, indicating a significant influx of fresh call positions rather than mere rotation of existing holdings. The expiry date for these options is 25 Aug 2026, less than a week away, underscoring the urgency of this directional bet.

This surge in call buying accompanied a 1.36% rise in the stock price, which has been on a two-day winning streak, cumulatively gaining 1.5%. The stock is trading just 0.81% below its 52-week high of Rs 8,674, suggesting that the options market is positioning for a potential breakout or sustained momentum in the near term. Divis Laboratories Ltd also outperformed its sector by 1.24% on the day, reinforcing the strength in the underlying equity.

Strike Price and Moneyness Analysis

The Rs 8,600 strike price is effectively at-the-money (ATM) given the underlying price of Rs 8,615. ATM calls are the most sensitive to price movements in the underlying stock, reflecting a bet on immediate directional movement rather than a speculative long-term target. This suggests that traders are positioning for a near-term move rather than a distant upside target.

Given the proximity to the 52-week high, the strike price selection reveals a conviction that the stock is at a critical juncture. The options flow is unambiguous in signalling a directional bias focused on the short-term horizon, with the expiry less than a week away. Divis Laboratories Ltd is thus at a decision point where small price changes could have outsized effects on option premiums.

Open Interest and Contracts Analysis

Open interest of 2,486 contracts against 5,924 traded contracts indicates that the recent activity is largely fresh positioning. A contracts-to-OI ratio above 2:1 is notable, as it implies that new money is entering the call options market rather than existing holders adjusting their positions. This fresh activity ahead of the 25 Aug expiry suggests a concentrated short-term directional bet.

Moreover, the turnover for these contracts was approximately ₹665.8 lakhs, reflecting substantial monetary commitment to this strike. The relatively high liquidity and turnover at this strike price further confirm that market participants are focused on this price level as a key battleground. Divis Laboratories Ltd’s options market is thus signalling a strong directional conviction.

Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.

  • - Consistent quarterly delivery
  • - Proven staying power
  • - Stability with growth

See the Consistent Performer →

Cash Market Context: Momentum and Moving Averages

Divis Laboratories Ltd is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — indicating a robust upward trend across multiple timeframes. This technical backdrop supports the directional positioning seen in the options market. The stock’s narrow trading range of Rs 13.5 on the day suggests consolidation near resistance, which aligns with the at-the-money call activity focused on the Rs 8,600 strike.

Despite the positive price momentum, delivery volumes tell a more nuanced story. On 17 Aug, delivery volume was 1.95 lakh shares, down 36.2% compared to the 5-day average. This decline in investor participation in the cash market contrasts with the surge in call option activity — is the options market anticipating a move that the cash market has yet to confirm? This divergence may reflect speculative positioning or hedging strategies rather than broad-based buying in the underlying shares.

Delivery Volume and Liquidity Considerations

The falling delivery volume amid rising call activity suggests that the derivatives market is currently the primary arena for directional bets on Divis Laboratories Ltd. However, the stock remains sufficiently liquid, with a 5-day average traded value supporting trade sizes of up to ₹7.52 crores, ensuring that both cash and derivatives markets can absorb sizeable transactions without undue price impact.

This liquidity profile supports the observed options activity, but the delivery volume decline raises questions about the sustainability of the current momentum in the cash market — should traders weigh the options flow more heavily than the cash market signals?

Curious about Divis Laboratories Ltd from Pharmaceuticals & Biotechnology? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!

  • - Detailed research coverage
  • - Technical + fundamental view
  • - Decision-ready insights

Get the Complete Analysis →

Key Data at a Glance

Strike Price
Rs 8,600
Underlying Price
Rs 8,615
Contracts Traded
5,924
Open Interest
2,486
Turnover
₹665.8 lakhs
Expiry Date
25 Aug 2026
Price Change (1D)
+1.36%
Delivery Volume Change
-36.2% vs 5-day avg

Conclusion: What the Options and Cash Data Signal

The heavy call option activity at the Rs 8,600 strike price, combined with the underlying stock trading just above this level, points to a focused short-term directional bet on Divis Laboratories Ltd. The contracts-to-open interest ratio suggests fresh money is entering the market, while the proximity to expiry adds urgency to this positioning.

However, the divergence between rising call activity and falling delivery volumes in the cash market introduces a note of caution. While the stock’s technicals remain strong, with prices above all major moving averages, the reduced investor participation in the underlying shares raises the question of whether the derivatives market is leading the cash market or reflecting speculative interest. Is this a momentum play worth joining or has the easy move already happened?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News